Anti-infection surgical implant in US trial
This article was originally published in Clinica
Executive Summary
Innocoll is pressing on with plans to begin a pivotal US clinical trial of its CollaRx gentamicin implant for preventing surgical site infection in patients undergoing open chest or abdominal surgery, as an adjunct to standard infection prophylaxis.